Enforcement Report - Week of April 12, 2023
Enforcement Report - Week of April 5, 2023
Enforcement Report - Week of March 8, 2023
Titan Pharmaceuticals has put plans for a trial of its candidate Parkinson’s disease implant ropinirole after the US FDA asked for additional information.